Trevena

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Trevena and other ETFs, options, and stocks.

About TRVN

Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045.

CEO

Carrie L. Bourdow

CEOCarrie L. Bourdow

Employees

Employees23

Headquarters

Chesterbrook, Pennsylvania

HeadquartersChesterbrook, Pennsylvania

Founded

2007

Founded2007

Employees

Employees23

TRVN Key Statistics

Market cap

7.53M

Market cap7.53M

Price-Earnings ratio

-0.13

Price-Earnings ratio-0.13

Dividend yield

—

Dividend yield—

Average volume

615.03K

Average volume615.03K

High today

$0.4199

High today$0.4199

Low today

$0.3702

Low today$0.3702

Open price

$0.38

Open price$0.38

Volume

114.90K

Volume114.90K

52 Week high

$3.28

52 Week high$3.28

52 Week low

$0.3001

52 Week low$0.3001

Trevena

Why Robinhood?

Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. Show more

TRVN Key Statistics

Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045.